Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Obesity Surgery
Erschienen in: Obesity Surgery 1/2023

Open Access 07.11.2022 | Original Contributions

2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery

verfasst von: Dan Eisenberg, Scott A. Shikora, Edo Aarts, Ali Aminian, Luigi Angrisani, Ricardo V. Cohen, Maurizio de Luca, Silvia L. Faria, Kasey P.S. Goodpaster, Ashraf Haddad, Jacques M. Himpens, Lilian Kow, Marina Kurian, Ken Loi, Kamal Mahawar, Abdelrahman Nimeri, Mary O’Kane, Pavlos K. Papasavas, Jaime Ponce, Janey S. A. Pratt, Ann M. Rogers, Kimberley E. Steele, Michel Suter, Shanu N. Kothari

Erschienen in: Obesity Surgery | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Major updates to 1991 National Institutes of Health guidelines for bariatric surgery

Metabolic and bariatric surgery (MBS) is recommended for individuals with a body mass index (BMI) >35 kg/m2, regardless of presence, absence, or severity of co-morbidities.
MBS should be considered for individuals with metabolic disease and BMI of 30-34.9 kg/m2.
BMI thresholds should be adjusted in the Asian population such that a BMI >25 kg/m2 suggests clinical obesity, and individuals with BMI >27.5 kg/m2 should be offered MBS.
Long-term results of MBS consistently demonstrate safety and efficacy.
Appropriately selected children and adolescents should be considered for MBS.
(Surg Obes Relat Dis 2022; https://​doi.​org/​10.​1016/​j.​soard.​2022.​08.​013) © 2022 American Society for Metabolic and Bariatric Surgery. All rights reserved.
Literatur
1.
Gastrointestinal surgery for severe obesity. Consens Statement 1991;9(1):1–20.
2.
Ogden CL, Carroll MD, Kit BK, Flegal KL. Prevalence of childhood and adult obesity in the United States 2011–12. JAMA. 2014;311(8):806–14.CrossRef
3.
4.
Gossman H, Butsch WS, Jastreboff AM. Treating the chronic disease of obesity. Med Clin N Am. 2021;105(6):983–1016.CrossRef
5.
Kawai T, Autieri MV, Scalia R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol. 2021;320(3):C375–91.CrossRef
6.
Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860–7.CrossRef
7.
Grosfeld A, Andre J, Hauguel-De Mouzon S, Berra E, Poussegur J, Guerre-Millo M. Hypoxia-inducible factor 1 transactivates the human leptin gene promoter. J Biol Chem. 2002;277(45):42953–7.CrossRef
8.
Chang SS, Eisenberg D, Zhao L, Adams C, Leib R, Morser J, Leung L. Chemerin activation in human obesity. Obesity (Silver Spring). 2016;24(7):1522–9.CrossRef
9.
Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, Bucher HC, Nordmann AJ. Bariatric surgery versus non-surgical treatment of obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934.CrossRef
10.
Adams TD, Davidson LE, Litwin SE, Kim J, Kolotkin RL, Nanjee MN, Gutierrez JM, Frogley SJ, Ibele AR, Brinton EA, Hopkins PN, McKinlay R, Simper SC, Hunt SC. Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med. 2017;377(12):1143–55.CrossRef
11.
Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.CrossRef
12.
Sjostrom L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65.CrossRef
13.
Puzziferri N, Roshek III TB, Mayo HG, Gallagher R, Belle SH, Livingston EH. Long-term follow-up after bariatric surgery: a systematic review. JAMA. 2014;312(9):935–42.CrossRef
14.
Maciewjewski ML, Arterburn DE, Van Scoyoc L, et al. Bariatric surgery and long-term durability of weight loss. JAMA Surg. 2016;151(11):1046–55.CrossRef
15.
Schauer PR, Mingrone G, Ikramuddin S, Wolfe B. Clinical outcomes of metabolic surgery: efficacy of glycemic control, weight loss, and remission of diabetes. Diabetes Care. 2016;39(6):902–11.CrossRef
16.
Arterburn DE, Olsen MK, Smith VA, Livingston EH, van Scoyoc L, Yancy Jr WS, Eid G, Weidenbacher H, Maciejewski ML. Association between bariatric surgery and long-term survival. JAMA. 2015;313(1):62–70.CrossRef
17.
Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.CrossRef
18.
Aminian A, Al-Kurd A, Wilson R, et al. Association of bariatric surgery with major adverse liver and cardiovascular outcomes in patients with biopsy-proven nonalcoholic steatohepatitis. JAMA. 2021;26(20):2031–42.CrossRef
19.
Aminian A, Zajicheck A, Arterburn DE, et al. Association of metabolic surgery with major adverse cardiovascular outcomes in patients with type 2 diabetes and obesity. JAMA. 2019;322(13):1271–82.CrossRef
20.
Goldberg I, Yang J, Nie L, Bates AT, Docimo Jr S, Pryor AD, Cohn T, Spaniolas K. Safety of bariatric surgery in patients older than 65 years. Surg Obes Relat Dis. 2019;15(8):1380–7.CrossRef
21.
Phillips BT, Shikora SA. The history of metabolic and bariatric surgery: development of standards for patient safety and efficacy. Metabolism. 2018;79:97–107.CrossRef
22.
Longitudinal Assessment of Bariatric Surgery (LABS) Consortium. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361:445–54.CrossRef
23.
Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007;142(4):621–32.CrossRef
24.
Arterburn DE, Telem DA, Kushner RF, Courcoulas AP. Benefits and risks of bariatric surgery in adults: a review. JAMA. 2020;324(9):879–87.CrossRef
25.
26.
27.
Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KG, Zimmet PZ, del Prato S, Ji L, Sadikot SM, Herman WH, Amiel SA, Kaplan LM, Taroncher-Oldenburg G, Cummings DE, Delegates of the 2nd Diabetes Surgery Summit. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Surg Obes Relat Dis. 2016;12(1):1144–62.CrossRef
28.
Aminian A, Chang J, Brethauer SA, Kim JJ, American Society for Metabolic and Bariatric Surgery Clinical Issues Committee. ASMBS updated position statement on bariatric surgery in class I obesity (BMI 30-35 kg/m2). Surg Obes Relat Dis. 2018;14(8):1071–87.CrossRef
29.
Noun R, Slim R, Nasr M, Chakhtoura G, Gharios J, Antoun NA, Ayoub E. Results of laparoscopic sleeve gastrectomy in 541 consecutive patients with low baseline body mass index (30-35 kg/m2). Obes Surg. 2016;26(12):2824–8.CrossRef
30.
Varban OA, Bonham AJ, Finks JF, Telem DA, Obeid NR, Ghaferi AA. Is it worth it? Determining the health benefits of sleeve gastrectomy in patients with a body mass index <35 kg/m2. Surg Obes Relat Dis. 2020;16(2):248–53.CrossRef
31.
Ikramuddin S, Komer J, Lee WJ, et al. Durability of addition of Roux-en-Y gastric bypass to lifestyle intervention and medical management in achieving primary treatment goals for uncontrolled type 2 diabetes in mild to moderate obesity: a randomized control trial. Diabetes Care. 2016;39(9):1510–8.CrossRef
32.
Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, Navaneethan SD, Singh RP, Pothier CE, Nissen SE, Kashyap SR, STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes – 5-year outcomes. N Engl J Med. 2017;376(7):641–51.CrossRef
33.
Courcoulas AP, Belle SH, Neiberg RH, Pierson SK, Eagleton JK, Kalarchian MA, DeLany JP, Lang W, Jakicic JM. Three-year out-comes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial. JAMA Surg. 2015;150(10):931–40.CrossRef
34.
O’Brien PE, Brennan L, Laurie C, Brown W. Intensive medical weight loss or laparoscopic adjustable gastric banding in the treatment of mild to moderate obesity: long-term follow-up of a prospective randomised trial. Obes Surg. 2013;23(9):1345–53.CrossRef
35.
Parikh M, Chung M, Sheth S, McMacken M, Zahra T, Saunders JK, Ude-Welcome A, Dunn V, Ogedegbe G, Schmidt AM, Pachter HL. Randomized pilot trial of bariatric surgery versus intensive medical weight management on diabetes remission in type 2 diabetes patients who do NOT meet NIH criteria for surgery and the role of soluble RAGE as a novel biomarker of success. Ann Surg. 2014;260(4):617–22.CrossRef
36.
Wentworth JM, Playfair J, Laurie C, Ritchie ME, Brown WA, Burton P, Shaw JE, O'Brien PE. Multidisciplinary diabetes care with and without bariatric surgery in overweight people: a randomised controlled trial. Lancet Diabetes Endocrinol. 2014;2(7):545–52.CrossRef
37.
Busetto L, Dixon J, De Luca M, Shikora S, Pories W, Angrisani L. Bariatric surgery in class I obesity: a position statement from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Obes Surg. 2014;24(4):487–519.CrossRef
38.
Rubino F, Cohen RV, Mingrone G, le Roux CW, Mechanick JI, Arterburn DE, Vidal J, Alberti G, Amiel SA, Batterham RL, Bornstein S, Chamseddine G, del Prato S, Dixon JB, Eckel RH, Hopkins D, McGowan BM, Pan A, Patel A, et al. Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgery. Lancet Diabetes Endocrinol. 2020;8(7):640–8.CrossRef
39.
40.
Misra A. Ethnic-specific criteria for classification of body mass index: a perspective for Asian Indians and American Diabetes Association position statement. Diabetes Technol Ther. 2015;17(9):667–71.CrossRef
41.
Hsu WC, Araneta MRG, Kanaya AM, Chiand JL, Fujimoto W. BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening. Diabetes Care. 2015;38(1):150–8.CrossRef
42.
Gill RS, Karmali S, Sharma AM. The potential role of the Edmonton obesity staging system in determining indications for bariatric surgery. Obes Surg. 2011;21(12):1947–9.CrossRef
43.
Padwal RS, Pajewski NM, Allison DB, Sharma AM. Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ. 2011;183(14):E1059–66.CrossRef
44.
Frattini F, Lavazza M, Rausei S, Rovera F, Boni L, Dionigi G. BMI: the weakness of a milestone in obesity management and treatment. Obes Surg. 2015;25(10):1940–1.CrossRef
45.
Al-Kurd A, Grinbaum R, Mordechay-Heyn T, et al. Outcomes of sleeve gastrectomy in septuagenarians. Obes Surg. 2018;28(12):3895–901.CrossRef
46.
Smith ME, Bacal D, Bonham AJ, Varban OA, Carlin AM, Ghaferi AA, Finks JF. Perioperative and 1-year outcomes of bariatric surgery in septuagenarians: implications for patient selection. Surg Obes Relat Dis. 2019;15(10):1805–11.CrossRef
47.
Edwards MA, Mazzei M, Agarwal S, Rhodes L, Bruff A. Exploring perioperative outcomes in metabolic and bariatric surgery amongst the elderly: an analysis of the 2015–2017 MBSAQIP database. Surg Obes Relat Dis. 2021;17(6):1096–106.CrossRef
48.
Watt J, Tricco AC, Talbot-Hamon C, Pham B’, Rios P, Grudniewicz A, Wong C, Sinclair D, Straus SE. Identifying older adults at risk of harm following elective surgery: a systematic review and meta-analysis. BMC Med. 2018;16(1):2.CrossRef
49.
Gondal AB, Hsu CH, Zeeshan M, Hamidi M, Joseph B, Ghaderi I. A frailty index and the impact of frailty on postoperative outcomes in older patients after bariatric surgery. Surg Obes Relat Dis. 2019;15(9):1582–8.CrossRef
50.
Reilly JJ, Kelly J. Long-term impact of overweight and obesity in childhood and adolescence on morbidity and premature mortality in adulthood: systematic review. Int J Obes (Lond). 2011;35(7):891–8.CrossRef
51.
Olbers T, Beamish AJ, Gronowitz E, Flodmark CE, Dahlgren J, Bruze G, Ekbom K, Friberg P, Göthberg G, Järvholm K, Karlsson J, Mårild S, Neovius M, Peltonen M, Marcus C. Laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity (AMOS): a prospective, 5-year, Swedish nationwide study. Lancet Diabetes Endocrinol. 2017;5(3):174–83.CrossRef
52.
Inge TH, Jenkins TM, Xanthakos SA, Dixon JB, Daniels SR, Zeller MH, Helmrath MA. Long-term outcomes of bariatric surgery in adolescents with severe obesity (FABS-5+): a prospective follow-up analysis. Lancet Diabetes Endocrinol. 2017;5(3):165–73.CrossRef
53.
Michalsky MP, Inge TH, Jenkins TM, et al. Teen-LABS consortium. Cardiovascular risk factors after adolescent bariatric surgery. Pediatrics. 2018;141(2):e20172485.CrossRef
54.
Inge TH, Laffel LM, Jenkins TM, Marcus MD, Leibel NI, Brandt ML, Haymond M, Urbina EM, Dolan LM, Zeitler PS, for the Teen–Longitudinal Assessment of Bariatric Surgery (Teen-LABS) and Treatment Options of Type 2 Diabetes in Adolescents and Youth (TODAY) Consortia. Comparison of surgical and medical therapy for type 2 diabetes in severely obese adolescents. JAMA Pediatr. 2018;172(5):452–60.CrossRef
55.
Inge TH, Courcoulas AP, Helmrath MA. Five-year outcomes of gastric bypass in adolescents as compared with adults. N Engl J Med. 2019;380(22):2136–45.CrossRef
56.
Alqahtani AR, Elahmedi M, Abdurabu HY, Alqahtani S. Ten-year outcomes of children and adolescents who underwent sleeve gastrectomy: weight loss, comorbidity resolution, adverse events, and growth velocity. J Am Coll Surg. 2021;233(6):657–64.CrossRef
57.
Pratt JSA, Browne A, Browne NT, Bruzoni M, Cohen M, Desai A, Inge T, Linden BC, Mattar SG, Michalsky M, Podkameni D, Reichard KW, Stanford FC, Zeller MH, Zitsman J. ASMBS pediatric metabolic and bariatric surgery guidelines, 2018. Surg Obes Relat Dis. 2018;14(7):882–901.CrossRef
58.
Armstrong SC, Bolling CF, Michalsky MP, Reichard KW, SECTION ON OBESITY, SECTION ON SURGERY, Haemer MA, Muth ND, Rausch JC, Rogers VW, Heiss KF, Besner GE, Downard CD, Fallat ME, Gow KW, FACS M. Pediatric metabolic and bariatric surgery: evidence, barriers, and best practices. Pediatrics. 2019;144(6):e20193223.CrossRef
59.
Jones RE, Wood LSY, Matheson BE, Pratt JSA, Burgart AM, Garza D, Shepard WE, Bruzoni M. Pilot evaluation of a multidisciplinary strategy for laparoscopic sleeve gastrectomy in adolescents and young adults with obesity and intellectual disabilities. Obes Surg. 2021;31(8):3883–7.CrossRef
60.
Khatod M, Cafri G, Namba RS, Inacio MCS, Paxton EW. Risk factors for total hip arthroplasty aseptic revision. J Arthroplasty. 2014;29(7):1412–7.CrossRef
61.
Namba RS, Inacio MCS, Paxton EW. Risk factors associated with surgical site infection in 30,491 primary total hip replacements. J Bone Joint Surg Br. 2012;94(10):1330–8.CrossRef
62.
Workgroup of the American Association of Hip and Knee Surgeons Evidence-Based Committee. Obesity and total joint arthroplasty: a literature-based review. J Arthroplasty. 2013;28(5):714–21.CrossRef
63.
Arsoy D, Woodcock JA, Lewallen DG, Trousdale RT. Outcomes and complications following total hip arthroplasty in the super-obese patient, BMI>50. J Arthroplasty. 2014;29(10):1899–905.CrossRef
64.
Issa K, Harwin SF, Malkani AL, Bonutti PM, Scillia A, Mont MA. Bariatric orthopaedics: total hip arthroplasty in super-obese patients (those with a BMI of >50 kg/m2). Bone Joint Surg Am. 2016;98(3):180–5.CrossRef
65.
Rajagopal R, Martin R, Howard JL, et al. Outcomes and complications of total hip replacement in super-obese patients. Bone Joint J. 2013;95-B(6):758–63.CrossRef
66.
McLawhorn AS, Levack AE, Lee YY, Ge Y, Do H, Dodwell ER. Bariatric surgery improves outcomes after lower extremity arthroplasty in the morbidly obese: a propensity score-matched analysis of a New York statewide database. J Arthroplasty. 2018;33(7):2062–9.CrossRef
67.
Davis AM, Wood AM, Keenan ACM, Brenkel IJ, Ballantyne JA. Does body mass index affect clinical outcome post-operatively and at five years after primary unilateral total hip replacement performed for osteoarthritis? A multivariate analysis of prospective data. J Bone Joint Surg Br. 2011;93(9):1178–82.CrossRef
68.
Inacio MC, Paxton EW, Fisher D, et al. Bariatric surgery prior to total joint arthroplasty may not provide dramatic improvements in post-arthroplasty surgical outcomes. J Arthroplasty. 2014;29(7):1359–64.CrossRef
69.
Severson EP, Singh JA, Browne JA, et al. Total knee arthroplasty in morbidly obese patients treated with bariatric surgery: a comparative study. J Arthroplasty. 2012;27(9):1696–700.CrossRef
70.
Kubat E, Giori NJ, Hwa K, Eisenberg D. Osteoarthritis in veterans undergoing bariatric surgery is associated with decreased excess weight loss: 5-year outcomes. Surg Obes Relat Dis. 2016;12(7):1426–30.CrossRef
71.
Werner BC, Kurkis GM, Gwathmey FW, Browne JA. Bariatric surgery prior to total knee arthroplasty is associated with fewer postoperative complications. J Arthroplasty. 2015;30(9):81–5.CrossRef
72.
Li S, Luo X, Sun H, Wang K, Zhang K, Sun X. Does prior bariatric surgery improve outcomes following total joint arthroplasty in the morbidly obese? A meta-analysis. J Arthroplasty. 2019;34(3):577–85.CrossRef
73.
Dowsey MM, Brown WA, Cochrane A, Burton PR, Liew D, Choong PF. Effect of bariatric surgery on risk of complications after total knee arthroplasty: A randomized clinical trial. JAMA Netw Open. 2022;5(4):e226722.CrossRef
74.
Geletzke AK, Rinaldi JM, Phillips BE, Mobley SB, Miller J, Dykes T, Hollenbeak C, Kelleher SL, Soybel DI. Prevalence of systemic inflammation and micronutrient imbalance in patients with complex abdominal hernias. J Gastrointest Surg. 2014;18(4):646–55.CrossRef
75.
Veilleux E, Lufti R. Obesity and ventral hernia repair: is there success in staging? J Laparoendosc Adv Surg Tech. 2020;30(8):896–9.CrossRef
76.
Novitsky YW, Orenstein SB. Effect of patient and hospital characteristics on outcomes of elective ventral hernia repair in the United States. Hernia. 2013;17(5):639–45.CrossRef
77.
Menzo ML, Hinojosa M, Carbonell A, et al. American Society for Metabolic and Bariatric Surgery and American Hernia Society consensus guideline on bariatric surgery and hernia surgery. Surg Obes Relat Dis. 2018;14(9):1221–32.CrossRef
78.
Yemini R, Nesher E, Carmeli I, Winkler J, Rahamimov R, Mor E, Keidar A. Bariatric surgery is efficacious and improves access to transplantation for morbidly obese renal transplant candidates. Obes Surg. 2019;29(8):2373–80.CrossRef
79.
Al-Bahri S, Fakhry TK, Gonzalvo JP, Murr MM. Bariatric surgery as a bridge to renal transplantation in patients with end-stage renal disease. Obes Surg. 2017;27(11):2951–5.CrossRef
80.
Lee Y, Tian C, Lovrics O, Soon MS, Doumouras AG, Anvari M, Hong D. Bariatric surgery before, during, and after liver transplantation: a systematic review and meta-analysis. Surg Obes Relat Dis. 2020;16(9):1336–47.CrossRef
81.
Yemini R, Nesher E, Braun M, Cohen M, Carmeli I, Mor E, Keidar A. Long-term outcomes of Roux-en-Y gastric bypass or sleeve gastrectomy in patients with cirrhosis; before, during or after liver transplantation: a single center’s experience. Clin Transplant. 2021;35(8):e14374.CrossRef
82.
Lee Y, Anvari S, Sam Soon M, Tian C, Wong JA, Hong D, Anvari M, Doumouras AG. Bariatric surgery as a bridge to heart transplantation in morbidly obese patients. A systematic review and meta-analysis. Cardiol Rev. 2022;30(8):1–7.CrossRef
83.
Lim CP, Fisher OM, Falkenback D, Boyd D, Hayward CS, Keogh A, Samaras K, MacDonald P, Lord RV. Bariatric surgery provides a “bridge to transplant” for morbidly obese patients with advanced heart failure and may obviate the need for transplantation. Obes Surg. 2016;26(3):486–93.CrossRef
84.
McElderry B, Alvarez P, Hanna M, Chaudhury P, Bhat P, Starling RC, Desai M, Mentias A. Outcomes of bariatric surgery in patients with left ventricular assist device. J Heart Lung Transplant. 2022;41(7):914–8.CrossRef
85.
Orandi BJ, Purvis JW, Cannon RM, Smith AB, Lewis CE, Terrault NA, Locke JE. Bariatric surgery to achieve transplant in end-stage organ disease patients: a systematic review and meta-analysis. Am J Surg. 2020;220(3):566–79.CrossRef
86.
Laurenius A, Taha O, Maleckas A, Lönroth H, Olbers T. Laparoscopic biliopancreatic diversion/duodenal switch or laparoscopic Roux-en-Y gastric bypass for super-obesity-weight loss versus side effects. Surg Obes Relat Dis. 2010;6(4):408–16.CrossRef
87.
Prachand VN, DaVee RT, Alverdy JC. Duodenal switch provides superior weight loss in the super-obese (BMI > 50 kg/m2) compared with the gastric bypass. Ann Surg. 2006;244(4):611–9.
88.
Whitlock G, Lewington S, Sherliker P, et al. Body mass index and cause-specific mortality in 900,000 adults: collaborative analyses of prospective studies. Lancet. 2009;373(9669):1083–96.CrossRef
89.
Flum DR, Belle SH, King WC, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361(5):445–54.CrossRef
90.
DeMaria EJ. Bariatric surgery for morbid obesity. N Engl J Med. 2007;356(21):2176–83.CrossRef
91.
Wilkinson KH, Helm M, Lak K, Higgins RM, Gould JC, Kindel TL. The risk of post-operative complications in super-superobesity compared to superobesity in accredited bariatric surgery centers. Obes Surg. 2019;29(9):2964–71.CrossRef
92.
Stephens DJ, Saunders JK, Belsley S, Trivedi A, Ewing DR, Iannace V, Capella RF, Wasielewski A, Moran S, Schmidt HJ, Ballantyne GH. Short-term outcomes for super-super obese (BMI >60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass. Surg Obes Relat Dis. 2008;4(3):408–15.CrossRef
93.
Roland JC, Needleman BJ, Muscarella P, Cook CH, Narula VK, Mikami DJ. Laparoscopic Roux-en-Y gastric bypass in patients with body mass index >70 kg/m2. Surg Obes Relat Dis. 2011;7(5):587–91.CrossRef
94.
Patton H, Heimbach J, McCullough A. AGA clinical practice update on bariatric surgery in cirrhosis: expert review. Clin Gastroenterol Hepatol. 2021;19(3):436–45.CrossRef
95.
Lassailly G, Caiazzo R, Ntandja-Wandji LC, Gnemmi V, Baud G, Verkindt H, Ningarhari M, Louvet A, Leteurtre E, Raverdy V, Dharancy S, Pattou F, Mathurin P. Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis. Gastroenterology. 2020;159(4):1290–301.CrossRef
96.
Ahmed S, Pouwels S, Parmar C, et al. Global bariatric research collaborative. Outcomes of bariatric surgery in patients with liver cirrhosis: a systematic review. Obes Surg. 2021;31(5):2255–67.CrossRef
97.
Mumtaz K, Lipshultz H, Jalil S, Porter K, Li N, Kelly SG, Conteh LF, Michaels A, Hanje J, Black S, Hussan H. Bariatric surgery in patients with cirrhosis: careful patient and surgery-type selection is key to improving outcomes. Obes Surg. 2020;30(9):3444–52.CrossRef
98.
Hanipah ZN, Punchai S, McCullough A, Dasarathy S, Brethauer SA, Aminian A, Schauer PR. Bariatric surgery in patients with cirrhosis and portal hypertension. Obes Surg. 2018;28(11):3431–8.CrossRef
99.
Hirji SA, Sabatino ME, Minhas AMK, Okoh AK, Fudim M, Vaduganathan M, Khan MS. Contemporary nationwide heart transplantation and left ventricular assist device outcomes in patients with histories of bariatric surgery. J Card Fail. 2022;28(2):330–3.CrossRef
100.
Yang TWW, Johari Y, Burton PR, Earnest A, Shaw K, Hare JL, Brown WA. Bariatric surgery in patients with severe heart failure. Obes Surg. 2020;30(8):2863–9.CrossRef
101.
McCloskey CA, Ramani GV, Mathier MA, et al. Bariatric surgery improves cardiac function in morbidly obese patients with severe cardiomyopathy. Surg Obes Relat Dis. 2007;3(5):503–7.CrossRef
102.
Punchai S, Hanipah ZN, Sharm G, et al. Laparoscopic sleeve gastrectomy in heart failure patients with left ventricular assist device. Obes Surg. 2019;29(4):1122–9.CrossRef
103.
Mechanick JL, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric surgery-2019 update: co-sponsored by the American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery, and American Society of Anesthesiologists – executive summary. Endoc Pract. 2019;25(12):1346–59.
104.
Carter J, Chang J, Birriel J, et al. ASMBS position statement on preoperative patient optimization before metabolic and bariatric surgery. Surg Obes Relat Dis. 2021;17(12):1956–76.CrossRef
105.
Eisenberg D, Lohnberg JA, Kubat EP, Bates CC, Greenberg LM, Frayne SM. Systems innovation model: an integrated interdisciplinary team approach pre- and post-bariatric surgery at a Veterans Affairs (VA) medical center. Surg Obes Relat Dis. 2017;13(4):600–6.CrossRef
106.
Mechanick JL, Kushner RF, Sugerman HJ, et al. American Association of Clinical Endocrinologists, The Obesity Society, and the American Society for Metabolic and Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Obesity (Silver Spring). 2009;17(Suppl 1):S1–70, v.
107.
Rebibo L, Marechal V, De Lameth I, et al. Compliance with a multidisciplinary team meeting’s decision prior to bariatric surgery protects against major postoperative complications. Surg Obes Relat Dis. 2017;13(9):1537–43.CrossRef
108.
Bullen NL, Parmar J, Gilbert J, Clarke M, Cota A, Finlay IG. How effective is the multidisciplinary team approach in bariatric surgery? Obes Surg. 2019;29(10):3232–8.CrossRef
109.
Kim J, Rogers A. Ballem, et al. ASMBS updated position statement on insurance mandated preoperative weight loss requirements. Surg Obes Relat Dis. 2016;12(5):955–9.CrossRef
110.
Andromalos L, Crowley N, Brown J, Craggs-Dino L, Handu D, Isom K, Lynch A, DellaValle D. Nutritional care in bariatric surgery: an Academy Evidence Analysis Center systematic review. J Acad Nutr Diet. 2019;119(4):678–86.CrossRef
111.
Sogg S, Lauretti J, West-Smith L. Recommendations for the presurgical psychosocial evaluation of bariatric surgery patients. Surg Obes Relat Dis. 2016;12(4):731–49.CrossRef
112.
Brethauer SA, Kim J, El Chaar M, et al. Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis. 2015;11(3):489–506.CrossRef
113.
Salminen P, Grönroos S, Helmiö M, Hurme S, Juuti A, Juusela R, Peromaa-Haavisto P, Leivonen M, Nuutila P, Ovaska J. Effect of laparoscopic sleeve gastrectomy vs Roux-en-Y gastric bypass on weight loss, comorbidities, and reflux at 10 years in adult patients with obesity: The SLEEVEPASS randomized clinical trial. JAMA Surg. 2022;157(8):656–66.CrossRef
114.
Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.CrossRef
115.
Arterburn DE, Wellman R, Emiliano A, Smith SR, Odegaard AO, Murali S, Williams N, Coleman KJ, Courcoulas A, Coley RY, Anau J, Pardee R, Toh S, Janning C, Cook A, Sturtevant J, Horgan C, McTigue KM, for the PCORnet Bariatric Study Collaborative. Comparative effectiveness and safety of bariatric procedures for weight loss: a PCORnet cohort study. Ann Intern Med. 2018;169(11):741–50.CrossRef
116.
Sjostrom L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014;311(22):2297–304.CrossRef
117.
O’Brien PE, Hindle A, Brennan L, Skinner S, Burton P, Smith A, Crosthwaite G, Brown W. Long-term outcomes after bariatric surgery: a systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single-centre review of 20-year outcomes after adjustable gastric banding. Obes Surg. 2019;29(1):3–14.CrossRef
118.
Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88.CrossRef
119.
Mentias A, Aminian A, Youssef D, Pandey A, Menon V, Cho L, Nissen SE, Desai MY. Long-term cardiovascular outcomes after bariatric surgery in the Medicare population. J Am Coll Cardiol. 2022;79(15):1429–37.CrossRef
120.
Ke Z, Zhou X, Sun F, Li F, Tong W, Zhu Z. Effect of bariatric surgery versus medical therapy on long-term cardiovascular risk in low BMI Chinese patients with type 2 diabetes: a propensity score-matched analysis. Surg Obes Relat Dis. 2022;18(4):475–83.CrossRef
121.
Colquitt JL, Picket K, Loveman E, Frampton GK. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014;2014(8):CD003641.
122.
Sjoholm K, Sjostrom E, Carlsson LMS, Peltonen M. Weight change-adjusted effects of gastric bypass surgery on glucose metabolism: 2- and 10-year results from the Swedish Obese Subjects (SOS) study. Diabetes Care. 2016;39(4):625–31.CrossRef
123.
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single centre, randomised controlled trial. Lancet. 2015;386(9997):964–73.CrossRef
124.
Docherty NG, le Roux CW. Bariatric surgery for the treatment of chronic kidney disease in obesity and type 2 diabetes mellitus. Nature Rev Nephr. 2020;16(12):709–20.CrossRef
125.
Morales E, Porrini E, Martin-Toboada M, et al. Renoprotective role of bariatric surgery in patients with established chronic kidney disease. Clin Kidney J. 2020;14(9):2037–46.CrossRef
126.
Cohen RV, Pereira TV, Aboud CM, et al. Effect of gastric bypass vs best medical treatment on early-stage chronic kidney disease in patients with type 2 diabetes and obesity. A randomized clinical trial. JAMA Surg. 2020;155(8):e200420.CrossRef
127.
Young L, Hanipah ZN, Brethauer SA, et al. Long-term impact of bariatric surgery in diabetic nephropathy. Surg Endosc. 2019;33(5):1654–60.CrossRef
128.
Li H, Boakye D, Chen X, Hoffmeiser M, Brenner H. Association of body mass index with risk of early-onset colorectal cancer: systematic review and meta-analysis. Am J Gastroenterol. 2021;116(11):2173–83.CrossRef
129.
Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K, International Agency for Research on Cancer Handbook Working Group. Body fatness and cancer-viewpoint of the IARC working group. N Engl J Med. 2016;375(8):794–8.CrossRef
130.
Schauer DP, Feigelson HS, Koebnick C, Caan B, Weinmann S, Leonard AC, Powers JD, Yenumula PR, Arterburn DE. Bariatric surgery and the risk of cancer in a large multisite cohort. Ann Surg. 2019;269(1):95–101.CrossRef
131.
Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care. 2012;35(11):2402–11.CrossRef
132.
Economides A, Giannakou K, Mamais I, Economides PA, Papageorgis P. Association between aggressive clinicopathologic features of papillary thyroid carcinoma and body mass index: A systematic review and meta-analysis. Fron Endocrinol (Lausanne). 2021;12:692879.CrossRef
133.
Shi J, Zhao L, Gao Y, Niu M, Yan M, Chen Y, Song Z, Ma X, Wang P, Tian J. Associating the risk of three urinary cancers with obesity and overweight: an overview with evidence mapping of systematic reviews. Syst Rev. 2021;10(1):58.CrossRef
134.
Adams TD, Hunt SC. Cancer and obesity: Effect of bariatric surgery. World J Surg. 2009;33(10):2028–33.CrossRef
135.
Sjostrom L, Gummesson A, Sjostrom CD, et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol. 2009;10(7):653–62.CrossRef
136.
Anveden A, Taube M, Peltonen M, Jacobson P, Andersson-Assarsson JC, Sjöholm K, Svensson PA, Carlsson LMS. Long-term incidence of female-specific cancer after bariatric surgery or usual care in the Swedish Obese Subjects Study. Gynecol Oncol. 2017;145(2):224–9.CrossRef
137.
Aminian A, Wilson R, Al-Kurd A, et al. Association of bariatric surgery with cancer risk and mortality in adults with obesity. JAMA. 2022;327(24):2423–33.CrossRef
138.
Tao W, Santoni G, von Euler-Chelpin M, Ljung R, Lynge E, Pukkala E, Ness-Jensen E, Romundstad P, Tryggvadottir L, Lagergren J. Cancer risk after bariatric surgery in a cohort study from the five Nordic countries. Obes Surg. 2020;30(10):3761–7.CrossRef
139.
Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, LaMonte MJ, Stroup AM, Hunt SC. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61.CrossRef
140.
Syn NL, Cummings DE, Wang LZ, Lin DJ, Zhao JJ, Loh M, Koh ZJ, Chew CA, Loo YE, Tai BC, Kim G, So JBY, Kaplan LM, Dixon JB, Shabbir A. Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174772 participants. Lancet. 2021;397(10287):1830–41.CrossRef
141.
Aleassa EM, Hassan M, Hayes K, Brethauer SA, Schauer PR, Aminian A. Effect of revisional bariatric surgery on type 2 diabetes mellitus. Surg Endosc. 2019;33(8):2642–8.CrossRef
142.
McKenna D, Selzer D, Burchett M, Choi J, Mattar SG. Revisional bariatric surgery is more effective for improving obesity related comorbidities than it is for reinducing major weight loss. Surg Obes Relat Dis. 2014;10(4):654–60.CrossRef
143.
Yan J, Cohen R, Aminian A. Reoperative bariatric surgery for treatment of type 2 diabetes mellitus. Surg Obes Relat Dis. 2017;13(8):1412–21.CrossRef
144.
Ma P, Reddy S, HIga KD. Revisional bariatric/metabolic surgery: what dictates its indications? Curr Atheroscler Rep. 2016;18(7):42.CrossRef
145.
Brethauer SA, Kothari S, Kallies K, et al. Systematic review on reoperative bariatric surgery: American Society for Metabolic and Bariatric Surgery Revision Task Force. Surg Obes Relat Dis. 2014;10(5):952–72.CrossRef
146.
Lazzati A, Bechet S, Jouma S, Paolino L, Jung C. Revision surgery after sleeve gastrectomy: a nationwide study with 10 years of follow-up. Surg Obes Relat Dis. 2020;16(10):1497–504.CrossRef
147.
Tran DD, Nwokeabia ID, Purnell S, Zafar SN, Ortega G, Hughes K, Fullum TM. Revision of Roux-en-Y gastric bypass for weight regain: a systematic review of techniques and outcomes. Obes Surg. 2016;26(7):1627–34.CrossRef
148.
Nevo N, Abu-Abeid S, Lahat G, Klausner J, Eldar SM. Converting a sleeve gastrectomy to a gastric bypass for weight loss failure – is it worth it? Obes Surg. 2018;28(2):364–8.CrossRef
Metadaten
Titel
2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery
verfasst von
Dan Eisenberg
Scott A. Shikora
Edo Aarts
Ali Aminian
Luigi Angrisani
Ricardo V. Cohen
Maurizio de Luca
Silvia L. Faria
Kasey P.S. Goodpaster
Ashraf Haddad
Jacques M. Himpens
Lilian Kow
Marina Kurian
Ken Loi
Kamal Mahawar
Abdelrahman Nimeri
Mary O’Kane
Pavlos K. Papasavas
Jaime Ponce
Janey S. A. Pratt
Ann M. Rogers
Kimberley E. Steele
Michel Suter
Shanu N. Kothari
Publikationsdatum
07.11.2022
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 1/2023
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-022-06332-1

Weitere Artikel der Ausgabe 1/2023

Obesity Surgery 1/2023 Zur Ausgabe

Review

A Literature Review of Taste Change and Zinc Deficiency After Bariatric Surgery: Could There Be a Causal Link?

Original Contributions

Reliability of Non-invasive Liver Fibrosis Assessment Tools Versus Biopsy in Pre- and Post-bariatric Surgery Patients with Non-alcoholic Fatty Liver Disease

Original Contributions

Incidence of Abnormalities of the Gastric Tube Following Sleeve Gastrectomy and Its Role on Esophagitis Progression

Letter to the Editor

Training and Certification for the Bariatric and Metabolic Surgery Specialization in Kazakhstan

Original Contributions

Outcomes of Patients with Severe Obesity and Cirrhosis with Portal Hypertension Undergoing Bariatric Surgery: a Systematic Review

Original Contributions

Effects of Peripheral Neural Blocks in Laparoscopic Sleeve Gastrectomy: a Pilot Study on Cognitive Functions in Severe Obese Patients

Neu im Fachgebiet Chirurgie

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.
Bildnachweise